Friday March 19 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
Biotechnology Equity prices/deals News and Headlines
Sign-up to BioPortfolio's
Biotechnology Equity Prices news alerts
.
Subscribe to
Share price RSS feed
-
-
View full RSS Index
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Aventis Pharma in good health
Moneycontrol.com:
similar ...
Capital Valmoris Inc. ("Valmoris"), Biotonix Inc. ("Biotonix") and Sylvain Guimond ("Guimond") Announce the Closing of Their Qualifying Transaction an
Yahoo! Canada:
similar ...
Tuesday`s Top Percentage Stock Movers (LXRX, SQNM, ADY, UWBK)
Earthtimes.org:
similar ...
Lexicon shares down on stock sale
Business Journal of Jacksonville:
similar ...
Genomic Health Inc. (GHDX) COO & CFO G Bradley Cole sells 2,500 Shares
Guru Focus:
similar ...
WebMD Health increases pricing of tender offer for common stock to $46.80 per share
News-Medical.Net:
similar ...
Ablynx Intends to Raise up to EUR57.5 Million with Secondary Public Offering - Price Range: EUR7.20 - EUR7.75
BioPortfolio:
similar ...
Lexicon Prices Offering
About:
similar ...
Harley-Davidson Rumored To Be Acquisition Target
About:
similar ...
Meridian Bioscience Inc. (VIVO) CEO John A Kraeutler sells 19,608 Shares
Guru Focus:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
MedIndia:
similar ...
BUYINS.NET: (VPHM) SqueezeTrigger Price is $13.232. There is $67,...
Zibb:
similar ...
BUYINS.NET: (VPHM) SqueezeTrigger Price is $13.232. There is $67,118,487.00 That Short Sellers Still Need To Cover
TradingMarkets:
similar ...
Ablynx Successfully Raises Eur50 Million With Secondary Public Offering - Final Price: Eur7.5 Per Share
NewsBlaze:
similar ...
Ablynx Successfully Raises Eur50 Million With Secondary Public Offering - Final Price: Eur7.5 Per Share
Pharmacy Choice:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Boston Business Journal:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Yahoo! Canada:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
St Louis Business Journal:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Dallas Business Chronicle:
similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Memphis Business Journal:
similar ...
